Synthetic flavonoids as protectors against doxorubicin-induced cardiotoxicity: VUF 5434, a more potent compound than monoHER.

被引：0
|
作者：
van Acker, F
Kedde, M
Kramer, K
Haenen, G
Bast, A
van der Vijgh, WJF
机构：
[1] Free Univ Amsterdam Hosp, Dept Med Oncol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Dept Safety & Environm Affairs, Amsterdam, Netherlands
[3] Univ Maastricht, Dept Pharmacol & Toxicol, Maastricht, Netherlands
来源：
CLINICAL CANCER RESEARCH | 2000年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
362
引用
收藏
页码：4538S / 4539S
页数：2
相关论文
共 17 条
  • [1] New synthetic flavonoids as potent protectors against doxorubicin-induced cardiotoxicity
    Van Acker, FAA
    Hulshof, JW
    Haenen, GRMM
    Menge, WMPB
    van der Vijgh, WJF
    Bast, A
    FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 (01) : 31 - 37
  • [2] Protectors against doxorubicin-induced cardiotoxicity: Flavonoids
    A. Bast
    H. Kaiserová
    G. J. M. den Hartog
    G. R. M. M. Haenen
    W. J. F. van der Vijgh1
    Cell Biology and Toxicology, 2007, 23 : 39 - 47
  • [3] Protectors against doxorubicin-induced cardiotoxicity:: Flavonoids
    Bast, A.
    Kaiserova, H.
    den Hartog, G. J. M.
    Haenen, G. R. M. M.
    van der Vijgh, W. J. F.
    CELL BIOLOGY AND TOXICOLOGY, 2007, 23 (01) : 39 - 47
  • [4] Protection against doxorubicin-induced cardiotoxicity by flavonoids
    Bast, A.
    TOXICOLOGY LETTERS, 2005, 158 : S9 - S9
  • [5] The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice
    Bruynzeel, Anna M. E.
    Mul, Paula P. N.
    Berkhof, Johannes
    Bast, Aalt
    Niessen, Hans W. M.
    van der Vijgh, Wim J. F.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (05) : 699 - 702
  • [6] The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice
    Anna M. E. Bruynzeel
    Paula P. N. Mul
    Johannes Berkhof
    Aalt Bast
    Hans W. M. Niessen
    Wim J. F. van der Vijgh
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 699 - 702
  • [7] The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review
    Syahputra, Rony Abdi
    Harahap, Urip
    Dalimunthe, Aminah
    Nasution, M. Pandapotan
    Satria, Denny
    MOLECULES, 2022, 27 (04):
  • [8] Flavonoids from Chromolaena leivensis and Caesalpinia spinosa as potential protectors against doxorubicin-induced cardiomyopathy
    Mancipe, Juan C.
    Vargas-Pinto, Pedro
    Gonzalez-Suarez, Daniela
    Rodriguez-Sanabria, Maria P.
    Rodriguez, Oscar E.
    Castellanos Londono, Iovana C.
    Santander, Sandra P.
    Pombo, Luis M.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2021, 111
  • [9] A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro
    Abou El Hassan, MAI
    Rabelink, MJWE
    van der Vijgh, WJF
    Bast, A
    Hoeben, RC
    BRITISH JOURNAL OF CANCER, 2003, 89 (11) : 2140 - 2146
  • [10] A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro
    M A I Abou El Hassan
    M J W E Rabelink
    W J F van der Vijgh
    A Bast
    R C Hoeben
    British Journal of Cancer, 2003, 89 : 2140 - 2146
12